Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

A combination of two existing skin cancer drugs and a third experimental drug could lead to a new strategy for treating patients who do not respond to existing therapies, a new study in mice suggests.

A survey of more than 200 researchers details impact of the pandemic. The scientists estimate their own research has been put back by six months through loss of access to labs, facilities, trials and samples. But they feel science has now adapted to COVID-19 – and researchers believe donations and Government support could accelerate recovery.